Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9EUR

Mpro WT from SARS-CoV-2 with 298Q mutation

9EUR の概要
エントリーDOI10.2210/pdb9eur/pdb
分子名称Replicase polyprotein 1a (2 entities in total)
機能のキーワードsars-cov-2, main protease, oligomerization, viral protein
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計33205.89
構造登録者
Plewka, J.,Lis, K.,Czarna, A.,Pyrc, K.,Kantyka, T.,Chykunova, Y. (登録日: 2024-03-28, 公開日: 2024-04-17, 最終更新日: 2024-04-24)
主引用文献Lis, K.,Plewka, J.,Menezes, F.,Bielecka, E.,Chykunova, Y.,Pustelny, K.,Niebling, S.,Garcia, A.S.,Garcia-Alai, M.,Popowicz, G.M.,Czarna, A.,Kantyka, T.,Pyrc, K.
SARS-CoV-2 M pro oligomerization as a potential target for therapy.
Int.J.Biol.Macromol., 267:131392-131392, 2024
Cited by
PubMed Abstract: The main protease (M) of SARS-CoV-2 is critical in the virus's replication cycle, facilitating the maturation of polyproteins into functional units. Due to its conservation across taxa, M is a promising target for broad-spectrum antiviral drugs. Targeting M with small molecule inhibitors, such as nirmatrelvir combined with ritonavir (Paxlovid™), which the FDA has approved for post-exposure treatment and prophylaxis, can effectively interrupt the replication process of the virus. A key aspect of M's function is its ability to form a functional dimer. However, the mechanics of dimerization and its influence on proteolytic activity remain less understood. In this study, we utilized biochemical, structural, and molecular modelling approaches to explore M dimerization. We evaluated critical residues, specifically Arg4 and Arg298, that are essential for dimerization. Our results show that changes in the oligomerization state of M directly affect its enzymatic activity and dimerization propensity. We discovered a synergistic relationship influencing dimer formation, involving both intra- and intermolecular interactions. These findings highlight the potential for developing allosteric inhibitors targeting M, offering promising new directions for therapeutic strategies.
PubMed: 38582483
DOI: 10.1016/j.ijbiomac.2024.131392
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.113 Å)
構造検証レポート
Validation report summary of 9eur
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon